Suchergebnisse - "Dougados, Maxime"

PubPharm (217)

1

Factors Associated With Treatment Pathways in Early Axial Spondyloarthritis : A Multistate Analysis of the 10-Year Follow-Up of the DESIR Cohort

enthalten in: The Journal of rheumatology | 2024

von Portier, E. | Chevret, S. | Walter-Petrich, A. | +3

2

Towards the Lowest Efficacious Dose : Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2024

von Kedra, J. | Dieudé, P. | Giboin, C. | +133

3

Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA) : data from the French multicentre retrospective FORSYA study

enthalten in: RMD open | 2024

von Dougados, M. | Lardy-Cléaud, A. | Desfleurs, E. | +7

4

Stricter treat-to-target in RA does not result in less radiographic progression : a longitudinal analysis in RA BIODAM

enthalten in: Rheumatology (Oxford, England) | 2023

von Ramiro, S. | Landewé, R. | van der Heijde, D. | +27

CommentIn: Rheumatology (Oxford). 2023 Sep 1;62(9):2944-2945. - PMID 36916723

5

Response to : 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial'' by Cai and Peng

enthalten in: Annals of the rheumatic diseases | 2023

von Molto, A. | van der Heijde, D. | Van den Bosch, F. | +1

CommentOn: Ann Rheum Dis. 2021 Nov;80(11):1436-1444. - PMID 33958325

6

Changes of anti-citrullinated peptide antibodies titers after biologic treatment in patients with rheumatoid arthritis : a systematic literature review and retrospective study

enthalten in: Clinical and experimental rheumatology | 2023

von Hilliquin, S. | Herrou, J. | Gutermann, L. | +6

7

Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies

enthalten in: JAMA network open | 2023

von Bitoun, S. | Hässler, S. | Ternant, D. | +40

8

Instrument selection for the ASAS core outcome set for axial spondyloarthritis

enthalten in: Annals of the rheumatic diseases | 2023

von Navarro-Compán, V. | Boel, A. | Boonen, A. | +24

9

Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis : data from the ESPOIR cohort

enthalten in: Clinical and experimental rheumatology | 2023

von Guellec, D. | Carvajal-Alegria, G. | Daïen, C. | +13

10

Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease : a post hoc analysis from ORAL Surveillance

enthalten in: Annals of the rheumatic diseases | 2023

von Charles-Schoeman, C. | Buch, M. | Dougados, M. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]